Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +2.96% slipped 0.30% to $164.36 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.63% rising 0.15% to 4,455.48 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.46% rising 0.10% to 34,798.00. Johnson & Johnson closed $15.56 below its 52-week high ($179.92), which the company achieved on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF -0.59% fell 0.80% to $372.00, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +2.36% rose 0.77% to $73.61, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +1.91% fell 0.57% to $43.94. Trading volume (4.4 M) remained 1.3 million below its 50-day average volume of 5.7 M.